IRIS
STEFANINI, Giulio Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.760
AS - Asia 6.807
EU - Europa 2.108
SA - Sud America 1.541
Continente sconosciuto - Info sul continente non disponibili 407
AF - Africa 293
OC - Oceania 17
Totale 20.933
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.520
SG - Singapore 4.190
BR - Brasile 1.286
CN - Cina 1.156
VN - Vietnam 648
IT - Italia 459
FI - Finlandia 375
IE - Irlanda 277
DE - Germania 214
NG - Nigeria 177
HK - Hong Kong 171
IN - India 168
FR - Francia 143
GB - Regno Unito 131
SE - Svezia 119
CA - Canada 109
AR - Argentina 103
NL - Olanda 103
BD - Bangladesh 76
MX - Messico 66
RU - Federazione Russa 55
TR - Turchia 53
IQ - Iraq 50
ID - Indonesia 43
EC - Ecuador 40
PL - Polonia 37
ES - Italia 36
JP - Giappone 31
UA - Ucraina 28
VE - Venezuela 28
ZA - Sudafrica 28
MA - Marocco 23
SA - Arabia Saudita 22
BE - Belgio 21
CO - Colombia 21
PK - Pakistan 20
PE - Perù 18
IL - Israele 17
MY - Malesia 17
PH - Filippine 17
CL - Cile 16
PY - Paraguay 16
UZ - Uzbekistan 15
DZ - Algeria 14
JM - Giamaica 14
AZ - Azerbaigian 13
GR - Grecia 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
AU - Australia 11
CR - Costa Rica 11
JO - Giordania 11
LT - Lituania 11
AT - Austria 10
PT - Portogallo 10
CZ - Repubblica Ceca 9
EG - Egitto 9
UY - Uruguay 9
NP - Nepal 8
RO - Romania 8
KZ - Kazakistan 7
TH - Thailandia 7
TW - Taiwan 7
CH - Svizzera 6
HN - Honduras 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
GT - Guatemala 5
KW - Kuwait 5
LB - Libano 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
IR - Iran 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
CU - Cuba 3
DK - Danimarca 3
ET - Etiopia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
NO - Norvegia 3
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
GE - Georgia 2
Totale 20.493
Salva come PNG Salva come JPEG
Città #
Singapore 1.923
Chandler 980
Ashburn 975
Wilmington 961
San Jose 742
The Dalles 608
Dallas 525
Shanghai 525
San Mateo 417
Helsinki 373
Beijing 285
Boardman 272
Dublin 271
New York 270
Ho Chi Minh City 235
Ann Arbor 228
Princeton 184
Lawrence 181
Benin City 177
Hanoi 165
Milan 163
Hong Kong 154
Los Angeles 152
Leawood 147
Santa Clara 120
São Paulo 117
Woodbridge 99
Paris 95
Fairfield 90
Amsterdam 86
Rome 72
Pune 57
Seattle 53
Buffalo 52
Chicago 43
London 41
Munich 36
Falkenstein 34
Warsaw 34
Phoenix 32
Montreal 31
Brasília 29
Orem 29
Rio de Janeiro 29
Belo Horizonte 28
Da Nang 27
Council Bluffs 26
Toronto 26
Chennai 25
Curitiba 25
Kocaeli 24
Mexico City 24
San Diego 24
Brooklyn 23
Tokyo 23
Charlotte 22
Norwalk 21
Brussels 20
Haiphong 20
Stockholm 20
Baghdad 19
San Francisco 19
Houston 18
Cologno Monzese 17
Boston 16
Campinas 16
Dhaka 16
Reston 16
Ribeirão Preto 16
Atlanta 15
Frankfurt am Main 15
Guarulhos 15
Assago 14
Guayaquil 14
Naples 14
Quito 14
The Bronx 14
Denver 13
Fortaleza 12
Johannesburg 12
Manchester 12
Moscow 12
Porto Alegre 12
Redmond 12
Baku 11
Buenos Aires 11
Hải Dương 11
Kingston 11
Kuala Lumpur 11
Nairobi 11
New Delhi 11
Tashkent 11
Abbiategrasso 10
Columbus 10
Miami 10
Queens 10
Redwood City 10
Turin 10
Amman 9
Caxias do Sul 9
Totale 12.989
Salva come PNG Salva come JPEG
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 147
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 138
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 131
Additive effect of anemia and renal impairment on long-term outcome after percutaneous coronary intervention. 119
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 118
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 116
2014 ESC/EACTS Guidelines on myocardial revascularization 115
2014 ESC/EACTS Guidelines on myocardial revascularization. 111
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients 111
CAD in TAVI patients: relevance of disease complexity 110
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 110
2018 ESC/EACTS Guidelines on myocardial revascularization 109
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 109
2014 ESC/EACTS Guidelines on myocardial revascularization 108
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 107
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New Generation Drug-Eluting Stents in the RESOLUTE All Comers Randomized Trial. 107
Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. 107
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 106
2018 ESC/EACTS Guidelines on myocardial revascularization. 105
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 104
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 103
What constitutes sufficient clinical evidence for stents? SpotLITE on the evaluation of novel coronary devices. 101
[Advances in the treatment of complex atherosclerotic disease: cracking the calcium and beyond] 100
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 100
2018 ESC/EACTS Guidelines on myocardial revascularization 99
A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug 99
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. 98
Does clinical data quality affect fluid-structure interaction simulations of patient-specific stenotic aortic valve models? 97
On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach 96
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 95
Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group 95
[Towards a standardized and minimalist future in interventional cardiology] 93
An update on drug-eluting stents versus bare-metal stents in PCI treatment: are there any remaining indications for BMS use? 93
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 92
Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. 92
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. 91
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 90
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 89
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 89
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 88
Efficacy and Safety of Calcium Channel Blocker/Diuretics Combination Therapy in Hypertensive Patients: A Meta-Analysis. 88
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis 88
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom (TM) drug-coated stent vs. the Gazelle (TM) bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy 88
Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11 943 Patients 88
Coronary stents: novel developments 87
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 87
Another reason to endorse and spread guidelines 87
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 86
Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review 86
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 86
The synergy stent in high-bleeding risk patients: why design matters 85
The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study 85
Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality 85
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 85
[SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention] 84
Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score 84
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 84
Coronary Artery Disease Severity and Aortic Stenosis: Clinical Outcomes According to SYNTAX-Score in Patients Undergoing Transcatheter Aortic Valve Implantation 84
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 83
New approach to direct stenting using a novel 'All-In-One' coronary stent system via 5 french diagnostic catheters: A pilot study 83
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 82
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 82
Surgical or percutaneous revascularization for isolated left anterior descending stenoses: are we in the same boat? 81
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 81
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 81
Impact of Right Ventricular Pacing in Patients With TAVR Undergoing Permanent Pacemaker Implantation 80
What's new in the 2018 ESC/EACTS guidelines on myocardial revascularization? 80
Can Coronary Computed Tomography Angiography Replace Invasive Angiography? Coronary Computed Tomography Angiography Cannot Replace Invasive Angiography 80
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. 80
Characterization of Myocardial Injury in Patients With COVID-19 80
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 79
Stent performance: never too late to sort it out. 79
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. 79
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 78
Safety and Efficacy of Resolute Zotarolimus-Eluting Stents Compared With Everolimus-Eluting Stents A Meta-Analysis 78
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes 77
Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials. 77
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention Results of a Nonrandomized Observational Study 77
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention: A Meta-Analysis of Randomized Trials 76
Management of ST-elevation myocardial infarction according to European and American guidelines. 76
State of the art: coronary artery stents - past, present and future. 76
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis 76
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 76
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques. 76
The Valsalva maneuver in the diagnosis of patent foramen ovale. 75
Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry 75
Severe aortic stenosis and coronary artery disease. 75
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 74
[Cardiac biomarkers in patients with COVID-19: pragmatic tools in hard times] 74
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. 74
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. 74
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. 74
Predictors of Adverse Events Among Patient Undergoing Primary Percutaneous Coronary Intervention - Insights From a Pooled Analysis of the COMFORTABLE-AMI and EXAMINATION trials 74
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 73
Myocardial revascularization appropriateness in Italy: Measuring the unmeasured 73
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial 73
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 73
Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19 72
Are the culprit lesions severely stenotic? 72
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. 72
Totale 8.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.578
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022878 0 9 16 245 6 2 21 148 73 68 246 44
2022/20232.885 421 110 236 313 315 206 13 213 514 287 197 60
2023/20242.132 222 151 406 128 105 275 153 128 20 49 196 299
2024/20253.368 45 32 43 32 60 351 281 330 478 837 416 463
2025/20269.092 1.377 683 500 871 313 460 2.541 473 465 581 314 514
2026/2027738 527 211 0 0 0 0 0 0 0 0 0 0
Totale 20.933